WallStreetZenWallStreetZen

NYSE: PBH
Prestige Consumer Healthcare Inc Stock

Overview
ForecastEarningsDividendOwnership
$60.82-0.14 (-0.23%)
Updated Feb 6, 2023
PBH Price
$60.82
Fair Value Price
N/A
Market Cap
$3.02B
52 Week Low
$48.51
52 Week High
$67.45
P/E
14.45x
P/B
1.79x
P/S
2.81x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.11B
Earnings
$210.33M
Gross Margin
56%
Operating Margin
30.01%
Profit Margin
19%
Debt to Equity
1.22
Operating Cash Flow
$234M
Beta
0.67
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

PBH Overview

Prestige Consumer Healthcare Inc. manufactures over-the-counter health and personal care products in the U.S. and internationally. Offerings include BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. It sells its products through mass merchandisers, and drug, food, dollar, convenience, and club stores, as well as online. Prestige Consumer Healthcare was founded in 1996 and is headquartered in Tarrytown, NY.

Zen Score

–
Industry Average (40)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PBH scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PBH ($60.82) is trading above its intrinsic value of $25.26, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PBH is good value based on its earnings relative to its share price (14.45x), compared to the US market average (14.99x)
P/E vs Market Valuation
PBH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more PBH due diligence checks available for Premium users.

Be the first to know about important PBH news, forecast changes, insider trades & much more!

PBH News

Valuation

PBH price to earnings (PE)

For valuing profitable companies with steady earnings
Company
14.45x
Industry
10.74x
Market
14.99x
PBH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PBH is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

PBH price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.79x
Industry
48.55x
PBH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PBH's financial health

Profit margin

Revenue
$275.5M
Net Income
$52.0M
Profit Margin
18.9%
PBH's Earnings (EBIT) of $332.73M... subscribe to Premium to read more.
Interest Coverage Financials
PBH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$3.7B
Liabilities
$2.1B
Debt to equity
1.22
PBH's short-term assets ($408.85M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PBH's long-term liabilities ($1.90B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PBH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PBH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$54.9M
Investing
-$1.8M
Financing
-$10.0M
PBH's operating cash flow ($233.86M)... subscribe to Premium to read more.
Debt Coverage Financials

PBH vs Medical Distribution Stocks

TickerMarket Cap1d %P/EP/B
PBH$3.02B-0.23%14.45x1.79x
PDCO$2.89B-1.88%14.50x2.77x
OMI$1.67B-2.23%13.19x1.73x
HSIC$11.69B-0.61%10.66x3.24x
CAH$19.85B-2.08%-16.49x-8.97x
View Top Medical Distribution Stocks

Prestige Consumer Healthcare Stock FAQ

What is Prestige Consumer Healthcare's quote symbol?

NYSE: PBH) Prestige Consumer Healthcare trades on the NYSE under the ticker symbol PBH. Prestige Consumer Healthcare stock quotes can also be displayed as NYSE: PBH.

If you're new to stock investing, here's how to buy Prestige Consumer Healthcare stock.

What is the 52 week high and low for Prestige Consumer Healthcare (NYSE: PBH)?

(NYSE: PBH) Prestige Consumer Healthcare's 52-week high was $67.45, and its 52-week low was $48.51. It is currently -9.83% from its 52-week high and 25.38% from its 52-week low.

How much is Prestige Consumer Healthcare stock worth today?

(NYSE: PBH) Prestige Consumer Healthcare currently has 49,687,668 outstanding shares. With Prestige Consumer Healthcare stock trading at $60.82 per share, the total value of Prestige Consumer Healthcare stock (market capitalization) is $3.02B.

Prestige Consumer Healthcare stock was originally listed at a price of $17.75 in Feb 10, 2005. If you had invested in Prestige Consumer Healthcare stock at $17.75, your return over the last 17 years would have been 242.65%, for an annualized return of 7.51% (not including any dividends or dividend reinvestments).

How much is Prestige Consumer Healthcare's stock price per share?

(NYSE: PBH) Prestige Consumer Healthcare stock price per share is $60.82 today (as of Feb 6, 2023).

What is Prestige Consumer Healthcare's Market Cap?

(NYSE: PBH) Prestige Consumer Healthcare's market cap is $3.02B, as of Feb 8, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Prestige Consumer Healthcare's market cap is calculated by multiplying PBH's current stock price of $60.82 by PBH's total outstanding shares of 49,687,668.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.